Sunitinib in patients with metastatic renal cell carcinoma of intermediate and high risk groups – Lithuanian National Cancer Institute retrospective analysis by V. Urbonas, A. Zalimas, D. Dabkeviciene, A. Ulys, A. Matulevicius, F. Jankevicius, S. Jarmalaite

Get full text